247 related articles for article (PubMed ID: 16014952)
21. The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation.
Chang PC; Cheng CY; Campbell M; Yang YC; Hsu HW; Chang TY; Chu CH; Lee YW; Hung CL; Lai SM; Tepper CG; Hsieh WP; Wang HW; Tang CY; Wang WC; Kung HJ
BMC Genomics; 2013 Nov; 14(1):824. PubMed ID: 24267727
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest.
Izumiya Y; Lin SF; Ellison TJ; Levy AM; Mayeur GL; Izumiya C; Kung HJ
J Virol; 2003 Sep; 77(17):9652-61. PubMed ID: 12915577
[TBL] [Abstract][Full Text] [Related]
23. The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein.
Tomita M; Choe J; Tsukazaki T; Mori N
Oncogene; 2004 Oct; 23(50):8272-81. PubMed ID: 15467747
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases.
Polson AG; Huang L; Lukac DM; Blethrow JD; Morgan DO; Burlingame AL; Ganem D
J Virol; 2001 Apr; 75(7):3175-84. PubMed ID: 11238844
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.
Lin SF; Robinson DR; Miller G; Kung HJ
J Virol; 1999 Mar; 73(3):1909-17. PubMed ID: 9971770
[TBL] [Abstract][Full Text] [Related]
26. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
Lukac DM; Garibyan L; Kirshner JR; Palmeri D; Ganem D
J Virol; 2001 Aug; 75(15):6786-99. PubMed ID: 11435557
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.
Wang Y; Li H; Chan MY; Zhu FX; Lukac DM; Yuan Y
J Virol; 2004 Aug; 78(16):8615-29. PubMed ID: 15280471
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
29. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication.
Xu Y; AuCoin DP; Huete AR; Cei SA; Hanson LJ; Pari GS
J Virol; 2005 Mar; 79(6):3479-87. PubMed ID: 15731242
[TBL] [Abstract][Full Text] [Related]
30. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
31. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus.
Seaman WT; Ye D; Wang RX; Hale EE; Weisse M; Quinlivan EB
Virology; 1999 Oct; 263(2):436-49. PubMed ID: 10544116
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
33. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
34. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
35. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
[TBL] [Abstract][Full Text] [Related]
36. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
[TBL] [Abstract][Full Text] [Related]
37. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the multimerization region of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) protein K-bZIP: the proposed leucine zipper region encodes a multimerization domain with an unusual structure.
Al Mehairi S; Cerasoli E; Sinclair AJ
J Virol; 2005 Jun; 79(12):7905-10. PubMed ID: 15919946
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus K15 gene.
Wong EL; Damania B
J Virol; 2006 Feb; 80(3):1385-92. PubMed ID: 16415016
[TBL] [Abstract][Full Text] [Related]
40. The UBC9 E2 SUMO conjugating enzyme binds the PR-Set7 histone methyltransferase to facilitate target gene repression.
Spektor TM; Congdon LM; Veerappan CS; Rice JC
PLoS One; 2011; 6(7):e22785. PubMed ID: 21829513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
